Takeda leads wave of orexin drugs with potential to upend narcolepsy market

AIMode News Desk · curated summary

August 19, 20261 min readHealth

Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.

Related coverage: Takeda leads wave of orexin drugs with potential to upend narcolepsy market biospace.com

About this story

This story was aggregated from biospace.com. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.

Read the full story →

For agents:JSON record OpenAPI WebMCP llms.txt

More in Health

Health

How Ebola became the deadliest outbreak in DR Congo’s history

Related coverage: How Ebola became the deadliest outbreak in DR Congo’s history Al Jazeera DR Congo’s Ebola outbreak ‘global emergency’ as infections pass 5,000: WHO Al Jazeera WHO says Congo Ebola outbreak can still be brought under control within three months Reuters Ebola in DRC: 'The evolution of this epidemic has exceeded our gravest expectations' outbreaknewstoday.substack.com WHO chief says most Ebola deaths in DR Congo still happening in the community CIDRAP

Al Jazeera · 5 hours ago

Health

Legends of Science and Surfing: Riding waves for cancer research

Related coverage: Legends of Science and Surfing: Riding waves for cancer research KPBS

KPBS · 5 hours ago

Health

FDA Approves First Drug to Treat a Cause of Narcolepsy

Related coverage: FDA Approves First Drug to Treat a Cause of Narcolepsy Time Magazine

Time Magazine · 6 hours ago

Health

FDA-Approved Drug Shows Promise for Reversing Osteoarthritis Damage

Related coverage: FDA-Approved Drug Shows Promise for Reversing Osteoarthritis Damage SciTechDaily

SciTechDaily · 6 hours ago